Biotech

All Articles

F 2G rears $100M for second attempt to get brand-new antifungal to market

.After F2G's 1st try to get a brand-new class of antifungal to market was thwarted due to the FDA, t...

Moderna targets $1.1 B in R&ampD spending cuts, drops 5 programs amidst earnings pressures

.Moderna has actually sworn to cut R&ampD spending through $1.1 billion by 2027. The selection to re...

Sanofi's $80M bet on Key dystrophy drug finishes in stage 3 fail

.Merely four months after Sanofi wager $80 million in beforehand cash money on Fulcrum Rehabs' losma...

Oncternal stock sinks 60% in the middle of unemployments, test firings

.Cancer cells firm Oncternal Therapeutics is actually folding all its professional tests as well as ...

Roche is holding out hopes that its injectable being overweight possibility could eventually display 25% effective weight loss in late-stage trial

.Roche is storing out chances that its injectable weight problems prospect can at some point illustr...

Novo Nordisk hails 'outstanding' fat burning lead for dual-acting oral medicine in early trial

.Novo Nordisk has elevated the cover on a phase 1 trial of its own dental amylin and also GLP-1 rece...

AbbVie sues BeiGene over blood cancer cells drug secret method

.Simply a couple of short full weeks after winning an FDA Fast lane tag for its investigational BTK ...

Lilly supplies one-two punch with second tranche of beneficial records on regular blood insulin prospect

.Quickly after a beneficial information drop for Eli Lilly's efsitora alfa, the Indianapolis-based b...

BridgeBio reduces genetics treatment budget as clinical records disappoint

.BridgeBio Pharma is actually lowering its own genetics therapy finances and also pulling back comin...

GSK gives up HSV vaccination really hopes after phase 2 neglect, yielding race to Moderna, BioNTech

.GSK's attempt to create the very first vaccine for herpes simplex infection (HSV) has actually ende...